Lisa M Deangelis Selected Research

Lisa M Deangelis Research Topics

Disease

15	Neoplasms (Cancer) 01/2018 - 06/2006
9	Lymphoma (Lymphomas) 03/2014 - 10/2004
9	Glioblastoma (Glioblastoma Multiforme) 05/2013 - 01/2010
6	Brain Neoplasms (Brain Tumor) 01/2019 - 09/2004
6	Glioma (Gliomas) 02/2013 - 01/2010
3	Meningioma (Meningiomas) 01/2010 - 12/2009
2	Neurologic Manifestations (Neurological Manifestations) 05/2013 - 09/2004
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Headache (Headaches) 05/2013
1	Stroke (Strokes) 05/2012
1	Thrombocytopenia (Thrombopenia) 08/2010
1	Hemorrhage 08/2010
1	Lymphopenia (Lymphocytopenia) 08/2010
1	Leukopenia 08/2010
1	Fatigue 08/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2009
1	Neuralgia (Stump Neuralgia) 04/2009
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2008
1	Melanoma (Melanoma, Malignant) 01/2008
1	Breast Neoplasms (Breast Cancer) 11/2007
1	Neoplasm Metastasis (Metastasis) 11/2007
1	Respiratory Insufficiency (Respiratory Failure) 04/2005

Drug/Important Bio-Agent (IBA)

5	Temozolomide (Temodar)FDA LinkGeneric 05/2013 - 07/2011
4	Methotrexate (Mexate)FDA LinkGeneric 03/2014 - 01/2006
3	SteroidsIBA 05/2013 - 10/2004
3	ErbB Receptors (EGF Receptor)IBA 10/2011 - 01/2010
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2010 - 01/2010
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2010 - 09/2004
2	Bevacizumab (Avastin)FDA Link 02/2013 - 04/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2012 - 08/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2012 - 07/2011
2	Pharmaceutical PreparationsIBA 01/2012 - 01/2010
2	Tyrosine Kinase InhibitorsIBA 10/2011 - 08/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2004 - 09/2004
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Cancer VaccinesIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	GlucocorticoidsIBA 05/2013
1	IGF-I-IGFBP-3 complex FDA Link 02/2013
1	Rituximab (Mabthera)FDA Link 01/2013
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2012
1	CilengitideIBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 12/2011
1	Biomarkers (Surrogate Marker)IBA 12/2011
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2011
1	GW 3965IBA 10/2011
1	LDL Receptors (LDL Receptor)IBA 10/2011
1	Sterol Regulatory Element Binding Protein 1IBA 10/2011
1	Lapatinib (GW572016)FDA Link 10/2011
1	Biological ProductsIBA 10/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2011
1	Liver X ReceptorsIBA 10/2011
1	CholesterolIBA 10/2011
1	epidermal growth factor receptor VIIIIBA 10/2011
1	Endothelial Growth FactorsIBA 07/2011
1	Proteins (Proteins, Gene)FDA Link 07/2011
1	afliberceptIBA 07/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2011
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2010
1	pazopanib FDA Link 08/2010
1	Angiogenesis InhibitorsIBA 08/2010
1	EnzymesIBA 01/2010
1	Gefitinib (Iressa)FDA Link 01/2010
1	Imatinib Mesylate (Gleevec)FDA Link 12/2009
1	Platelet-Derived Growth FactorIBA 12/2009
1	AntigensIBA 01/2008
1	Capecitabine (Xeloda)FDA Link 11/2007
1	Hormones (Hormone)IBA 04/2005
1	GadoliniumIBA 04/2005
1	AnticoagulantsIBA 09/2004

Therapy/Procedure

11	Therapeutics 01/2018 - 09/2004
8	Drug Therapy (Chemotherapy) 01/2012 - 10/2005
5	Radiotherapy 05/2013 - 10/2005
1	Contraindications 05/2012
1	Drug Tapering 08/2010
1	Salvage Therapy 07/2007